higher risk of perioperative cardiac and/or thromboembolic events. Therefore, consideration of the role of comorbidities and the interaction with antirheumatic therapy should also be pursued. In summary, this guideline provides an update to the ACR/AAHKS 2017 guideline to provide clinicians and patients information about risks and benefits regarding management of perioperative antirheumatic medication to inform decisions prior to THA and TKA. We have updated our evidence base through our search